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INTRODUCTION
Leishmaniases are vector-borne tropical diseases caused by protozoa of the Leishmania genus, characterized by a wide clinical spectrum and symptoms ranging from self-healing cuta-neous lesions to lethal visceral disease. Leishmaniases are among of the most neglected infectious diseases with endemicity in 88 countries and affecting 12 million people worldwide. The annual incidence is around 2 million cases, including both visceral and cutaneous diseases (Alvar et al., 2012) . In the Americas, L. (Viannia) braziliensis is the predominant species causing American tegumentary leishmaniasis (ATL), characterized by localized cutaneous leishmaniasis (LCL), disseminated cutaneous leishmaniasis (DL), and mucosal leishmaniasis (ML) (Goto and Lauletta Lindoso, 2012) . In the absence of efficient strategies to prevent infections with Leishmania parasites and to control the transmission of the parasites by vector insects, the treatment of leishmaniasis relies on drug therapy. Pentavalent antimony has been the first line of treatment for decades. This drug is expensive for low and middle-income countries and requires several injections that are toxic and painful. Furthermore, there is emergence of parasite resistance to antimonial drugs, and the rate of treatment failure affects more than 47% of the cases. In some endemic areas, where the efficacy of pentavalent antimonial is very low, it is replaced by other more effective drugs such as amphotericin B and miltefosine (Barroso et al., 2007; Khamesipour, 2014; Machado et al., 2010) .
Leishmania is an intracellular parasite that can be taken up by phagocytic cells, including neutrophils, monocytes, macrophages, and resident dendritic cells. In macrophages, there is the best evidence for parasite replication and long term-survival (Beattie and Kaye, 2011) . Therefore, targeting macrophages to enhance or modulate their antimicrobial function may facilitate the development of novel therapeutic strategies. Among the effector mechanisms used by macrophages to control Leishmania replication are reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI). Activation of macrophages is dependent on interferon gamma (IFNg) and tumor necrosis factor (TNF-a) (Bottrel et al., 2001; Ibraim et al., 2013; Liese et al., 2008) . Additionally, studies have shown that macrophage interleukin (IL)-1b signaling is important for controlling parasite replication and influences the clinical course of Leishmaniasis (Lima-Junior et al., 2013; Novais et al., 2017) .
Recently, our group identified interleukin 32 (IL-32), an intracellular cytokine produced in different isoforms by immune and non-immune cells, as a pivotal mediator in controlling infections caused by New World Leishmania spp. . IL-32g is expressed in lesions of patients infected with L. (V.) braziliensis or L. (L.) amazonensis (Galdino et al., 2014; Gomes et al., 2017) . In addition, infection of human macrophages with Leishmania induces intracellular IL-32g expression. Once produced, IL-32g is associated with the production of TNF-a, nitric oxide (NO) , and antimicrobial peptides such as cathelicidin and b-defensin 2 (Dos Santos et al., 2017b) . Moreover, Leishmania infection of human IL-32g transgenic (IL-32gTG) mice resulted in improved control of lesions caused by L. braziliensis in association with an increase of IFNg, TNF-a, and IL-10 production (Gomes et al., 2017) .
Clinical improvement in the treatment of ATL with Bacillus Calmette-Gué rin (BCG) vaccination has been reported previously (Convit et al., 2004) . In addition, we recently confirmed that BCG vaccination in combination with conventional treatment can increase circulating natural killer (NK) cells and proinflammatory monocytes, contributing to clinical remission of several lesions in a patient with diffuse cutaneous leishmaniasis (DCL) caused by L. (L.) amazonensis (Pereira et al., 2009 ). Similarly, Obaid et al. (1989) observed that b-glucan (a cell wall component of Candida albicans) as adjuvant together with Leishmania antigens lead to protection against L. (L.) donovani in hamsters.
In monocytes and macrophages, BCG and b-glucan induce non-specific protection to secondary infections by long-term functional reprogramming via a process called trained immunity, which is dependent on metabolic and epigenetic changes, such as lysine methyl modifications (H3 histones monomethylated [H3K4me1] or trimethylated [H3K4me3] at lysine 4) (Arts et al., 2016; Netea et al., 2016; Quintin et al., 2012) . We therefore hypothesized that exposure of monocytes to b-glucan may induce non-specific protection against intracellular infection caused by Leishmania spp., which could offer novel immunotherapeutic strategies to patients with leishmaniasis. In both human primary cells and a murine model of trained immunity, we assessed the effects of b-glucan or BCG training in monocytes and macrophages using various biochemical and molecular approaches. In addition, we investigated the role of IL-32g and IL-1 signaling for b-glucan-induced trained immunity.
RESULTS
b-Glucan-Induced Trained Immunity Controls L. braziliensis Infection in Primary Human Macrophages Because trained immunity has been reported to protect against non-specific infections, we investigated whether training induced by b-glucan could control infection caused by L. braziliensis. Human primary monocytes incubated with b-glucan for 24 h were washed and incubated in normal culture conditions for an additional 5 days and infected at day 6 with promastigote forms of L. braziliensis. Production of TNF-a, IL-6, and IL-10 was evaluated after 2 h, 4 h, and 24 h of infection (Figure 1A) . Training of monocytes with b-glucan induced higher TNF-a and IL-6 production after stimulation with LPS, compared to control cells (Figures S1A and S1B). L. braziliensis infection did not induce these cytokines in naive macrophages, whereas a significant increase in IL-6 and IL-10 production was observed after 2 h and 4 h of infection in b-glucan-trained macrophages ( Figures 1B-1D ). In parallel, a greater percentage of macrophages had ingested the parasite after training with b-glucan at these time points ( Figure 1E ). Remarkably, after 24 h of infection, the percentage of infected macrophages strongly decreased in b-glucan-treated macrophages ( Figure 1E ). Similar results were observed with regard to the number of parasites per infected cell and infection index (Figures 1F and 1G) . Interestingly, the number of parasites per infected cell was significantly decreased as early as 4 h after infection, indicating rapid killing of the parasites in b-glucan-trained cells ( Figure 1F ). Accordingly, b-glucan-trained macrophages contained 3-fold less live parasites compared to control macrophages ( Figure S1C ). Macrophages death was monitored by measuring the release of lactate dehydrogenase (LDH). LDH concentrations remained stable in both b-glucan-trained and control macrophages after infection ( Figure S1D ).
To investigate potential mechanisms underlying these initial observations, we evaluated whether known microbicidal molecules such as ROS, NO, cathelicidin, and b-defesin could explain the better parasite control in b-glucan-trained primary macrophages. No differences in ROS or NO production were observed when comparing trained or non-trained macrophages (Figures S2A and S2B) . In contrast, cathelicidin and b-defensin 2 mRNA expression were significantly increased in b-glucan-trained macrophages ( Figures S2C and S2D ).
b-Glucan-Induced Epigenetic Modifications Results in Upregulation of IL-32 Expression in Human Macrophages
We previously described a role for IL-32-dependent cathelicidin and b-defensin 2 expression in host defense against Leishmania spp. (Dos Santos et al., 2017b) , thus prompting us to explore if IL-32 was involved in b-glucan induced protection against L. braziliensis infection in human macrophages. In accordance with our hypothesis, IL-32g mRNA expression as well as intracellular IL-32 protein levels were significantly increased in b-glucan-trained macrophages (Figures 2A and 2B ). Furthermore, when b-glucan-trained cells were infected with L. braziliensis, the intracellular IL-32 protein levels were increased compared to control cells ( Figure 2C ). These results indicated that IL-32 is upregulated on a transcriptional level. Indeed, intracellular IL-32 expression was previously shown to be influenced by genetic variation in the IL-32 promoter region (https://genenetwork.nl/ bloodeqtlbrowser; Westra et al., 2013) . Using the 200FG cohort of healthy volunteers, we examined whether the IL32 promoter single nucleotide polymorphism (SNP) rs4786370 could interfere with b-glucan-induced trained immunity. The presence of CC genotype was associated with greater production of TNF-a and IL-6 compared with the CT and TT genotypes ( Figures 2D and 2E ). Additionally, in individuals carrying the CC genotype, a tendency to higher production of lactate was observed compared with the TT genotype ( Figure 2F ).
To investigate whether the IL32 rs4786370 SNP could influence the production of intracellular IL-32 and infection index during the training with b-glucan, we stratified the healthy volunteers based on their genotype. The tendency of higher production of IL-32 was observed in individuals carrying the CC genotype compared with those carrying the TT genotype in b-glucantrained macrophages after the infection with L. braziliensis (Figure 2G) . In parallel, the infection index pointed toward a decreased infection rate in the individuals carrying the CC genotype compared with the TT genotype ( Figure 2H ). Interestingly, a negative correlation between the levels of intracellular IL-32 and the infection index in the individuals carrying the CC genotype was observed ( Figure 2I ). These results suggested that trained immunity phenotype induced by b-glucan is mediated by IL-32.
We next examined the chromatin landscape surrounding IL-32 expression in cells trained with b-glucan. Levels of H3 histones trimethylated at lysine 4 (H3K4me3), a marker generally associated with transcriptional activation, were unexpectedly depleted from the IL-32 promoter region in trained cells ( Figure 2J ). Furthermore, transcriptionally repressive lysine 9 trimethylation of H3 histones (H3K9me3) was not significantly altered by b-glucan training ( Figure 2K ). A recent study identified a distal regulatory element that is crucial for IL-32 transcriptional regulation in CD4 + T cells (Palstra et al., 2018) . Activation of such elements can be epigenetically distinguished by enrichment for H3 histones monomethylated at lysine 4 (H3K4m1) (Catarino and Stark, 2018) . Paralleling the transcriptional upregulation of IL-32, we observed significant enrichment of H3K4m1 at the distal enhancer region ( Figure 2L ).
Human Monocyte Training with b-Glucan Is Dependent on IL-32g Expression and IL-1 Signaling Trained immunity induced by b-glucan is reported to be dependent on bioactive IL-1b production in mice (Christ et al., 2018; Mitroulis et al., 2018) . Moreover, IL-1b induces IL-32 production . To further investigate whether IL-1b and IL-32 (legend continued on next page) was associated with the training induced by b-glucan in primary human cells, the production of IL-1b were assessed in the individuals carrying the different genotypes of the IL32 rs4786370 SNP. The results showed a higher production of both secreted IL-1b and intracellular IL-1b by individuals carrying the CC genotype compared with the TT genotype during the first 24 h of exposure with b-glucan ( Figures 3A and 3B ). The treatment of primary monocytes with human IL-1b resulted in a significant increase in IL-32g mRNA expression as well as intracellular IL-32 protein levels ( Figures 3C and 3D ). Further, we examined the effect of genetic variations in IL-1/IL-1R genes on b-glucan-induced trained immunity. Cytokine production was significantly decreased when there were polymorphisms located in the promoter region of the IL-1b-encoding gene (IL-1b; rs16944) ( Figures 3E and 3F ) or a missense SNP in the IL-1a gene (IL-1a, rs17561) ( Figures  3G and 3H ), respectively. Similarly, an intronic SNP on IL1RAP (interleukin 1 receptor accessory protein; rs34590034) gene also influenced the training capacity of monocytes by decreasing the production of TNF-a by individuals carrying the TT genotype compared to AA and AT genotypes ( Figure 3I ).
The effects of impaired IL-1 signaling could be ascribed to a decrease in IL-32 production. In fact, when monocytes were trained with b-glucan in the presence of interleukin-1 receptor antagonist (IL-1Ra), we observed lower levels of IL-32g mRNA than monocytes trained in the absence of IL-1Ra ( Figure 3J ). Additionally, when these macrophages were infected with L. braziliensis, we observed a significant higher infection index than monocytes trained in the absence of IL-1Ra ( Figure 3K ). The importance of IL-1b for b-glucan-induced training was confirmed by a reduction in TNF-a and IL-6 production when cells were trained in the presence of IL-1Ra and challenged after 6 days of culture with LPS ( Figures S3A and S3B ). Thus, we showed that b-glucan-induced trained immunity is regulated by the expression of IL-32 and IL-1 signaling, which is important for the control of L. braziliensis infection.
b-Glucan-Induced Trained Immunity in Human IL-32g Transgenic Mice Improves Resistance to Leishmania braziliensis Because IL-32 is not expressed in rodents to further confirm that IL-32g is important for b-glucan training and control of L. braziliensis infection, we performed experiments with human IL-32g transgenic mice (IL-32gTG) . Recently, it was reported that b-glucan-induced trained immunity in C57BL/6 mice induced proliferation of bone marrow progenitors of myeloid lineage, which was associated with increased production of innate immune mediators such as IL-1b, and with adaptations in cell metabolism (Mitroulis et al., 2018) . Next, we investigated whether b-glucan also induces changes in bone marrow cells (BM) of IL-32gTG mice. Human IL-32gTG mice received intra-peritoneal b-glucan injections, and after 7 days, bone marrow cells were analyzed. An increased cellularity was observed in the b-glucan-injected group compared to the PBS control animals ( Figure 4A ). Furthermore, b-glucan-treated mice displayed higher expression of mki67 and csf2rb mRNA, which are genes related to cell-cycle regulation and a myeloid lineage marker, respectively ( Figures 4B and 4C ). Of note, rag2 gene expression that is a lymphoid cell marker was downregulated in b-glucan-injected group compared to the PBS control animals ( Figure 4D ). We next analyzed IL-32 expression after 24 h of ex vivo stimulation with LPS or L. braziliensis lysates. Levels of IL-32g and IL-1b mRNA were significantly higher in BM cells from the b-glucan-injected mice compared with cells from the PBS group after stimulation with either LPS or lysates of L. braziliensis (Figures 4E and 4F ). Besides cytokines, expression of genes encoding key regulatory enzymes of the glycolytic pathway was evaluated. We observed significantly increased expression of hif-1a, pfkp3, and hk3 mRNA expression in BM cells from b-glucan-injected mice in comparison with cells from PBS-injected IL-32gTG mice ( Figures 4G-4I ).
These results indicated that IL-32gTG mice can be trained by b-glucan, leading to metabolic alterations and an improved immune response to L. braziliensis antigens. Thus, we further explored whether b-glucan could induce protection against L. braziliensis infection in vivo in IL-32gTG mice. To this end, either wild-type (WT) C57BL/6 or IL-32gTG mice were injected with b-glucan or PBS and infected 7 days later with stationaryphase promastigotes of L. braziliensis ( Figure 5A ). b-glucantrained IL-32gTG mice showed a significant increase in lesion size after 3 weeks of infection compared with the PBS control group. Remarkably, after week 5 of infection, a significant decrease in lesion size was observed in b-glucan-trained mice. Nevertheless, no significant differences in lesion size were observed in b-glucan-trained WT mice compared with the PBS control group ( Figure 5B ). At the later stages of the infection, a significant decrease in parasite load was observed in b-glucan-trained IL-32gTG mice compared with the PBS group. Consistent with the lesion size, no differences in parasite load were observed in b-glucan-trained WT mice (8 weeks, Figure 5C ). Furthermore, no significant differences in TNF-a and IL-32 levels were observed at this time point ( Figures 5D and 5E ).
The increased size of the lesion on the third week of infection observed in the b-glucan-trained mice could be ascribed to a marked increase in the inflammatory infiltrate ( Figures 6B-6D ). After 8 weeks of infection, b-glucan-trained IL-32gTG mice showed a significant reduction of inflammation when compared with the PBS group ( Figures 6E-6G ). Contrary to the IL-32gTG mice, when b-glucan-trained WT mice were compared with the PBS group, no significant difference in the inflammatory infiltrate was observed ( Figures 6H-6J ).
(G and H) After training with b-glucan, macrophages from individuals carrying the CC and TT genotypes of IL32 rs4786370 SNP were infected with stationaryphase L. braziliensis promastigotes. Intracellular IL-32 protein (G) was measured and the infection index (H) was determined. The data shown are the mean ± SEM; n = 5 CC and n = 4 TT. (I) Correlation of IL-32 with infection index in individuals carrying the CC genotype of IL32 rs4786370 SNP. (J-L) Chromatin was fixated on day 6 and chromatin immunoprecipitation (ChIP)-qPCR was performed. H3K4me3 (J) and H3K9me3 (K) were determined at the promoter of IL-32 gene (P1 and P2). H3K4me1 (L) was determined at the distal enhancer region of IL-32 gene (E1 and E2). The data shown are the mean ± SEM. Results are compiled from at least two experiments. n = 6. *p < 0.05 (RPMI versus b-glucan; by Wilcoxon test).
Because IL-32 and IL-1b seem to play a pivotal role in the control of the infection caused by L. braziliensis in b-glucan-trained macrophages, we evaluated whether these two cytokines as well as macrophages-like cells were present in the lesion of IL-32gTG mice. The predominant cells in the lesions were macrophage-like (F4/80 + ) cells in both b-glucan-trained or PBS-treated IL-32gTG mice after 3 weeks and 8 weeks of infection. Furthermore, we observed that IL-32 protein was mainly expressed in b-glucan-trained mice. Of note, the high expression of IL-1b at week 3 after infection in b-glucan-trained mice compared with the PBS group provide an extra evidence supporting the concept that IL-32 and IL-1b are closely associated with the b-glucan-induced trained immunity ( Figure S4) . 
Intracellular IL-32 Expression
Determines the Gene Transcription Profile in Bone Marrow-Derived HSPC and GMP Cells 90 Days after BCG Vaccination of Human Volunteers BCG vaccination has been shown to induce effects similar to that of b-glucan at the level of the hematopoietic stem cells within the bone marrow resulting in an enhanced training ability (Kaufmann et al., 2018; Mitroulis et al., 2018) . Because b-glucan is not yet ready to be used as a therapeutic option to treat human diseases (Leentjens et al., 2014) , to gain further insight into the mechanism by which IL32 rs4786370 SNP enhances the induction of trained innate immunity, we evaluate the gene expression in bone marrow hematopoietic stem and progenitor cells (HSPC, consisting of hematopoietic stem cells and multi-potent progenitors) and granulocyte macrophage progenitors (GMP) of healthy volunteers before BCG vaccination on day 0 (D0) and on day 90 (D90) post BCG vaccination ( Figure 7A ). We focused our analyses on genes differently expressed specifically between rs4786370 CT_TT and CC BM cells. At day 0, prior to BCG vaccination, IL32 expression was similar in the individuals carrying the IL32 rs4786370 CT_TT and CC genotypes in both GMP and HSPC BM cells ( Figure 7B ). We next analyzed IL32 expression in GMP cells after BCG vaccination. Of note, mean IL32 expression in GMP cells was already modulated at day 0 after BCG exposure in individuals carrying the IL32 rs4786370 CC genotype and remained unaltered after 3 months of vaccination ( Figure 7B ). However, after BCG vaccination, IL32 expression in HSPC cells was modulated within the different time points. Interestingly, 3 months (M3) after exposure to BCG, IL32 expression was higher in the individuals carrying the IL32 rs4786370 CC genotype when compared with individuals carrying IL32 rs4786370 CT_TT ( Figure 7B) .
We next investigated genes that were differentially expressed in GMP and HSPC BM cells of individuals carrying the IL32 rs4786370 genotypes post BCG vaccination. When we looked at the genes expressed in the GMP BM cells, we found some genes that were specifically upregulated in the IL32 rs4786370 CC individuals 3 months (D90) post vaccination. Among these were genes related to cell metabolism such as oxidative stress-associated Src activator (FAM120A), which is a critical component of the oxidative stress-induced survival signaling (Tanaka et al., 2009 ), C2 calcium-dependent domain containing 4 (C2CD5), which encodes one of the proteins required for insulin-stimulated glucose transport, and glucose transporter SLC2A4/GLUT4 translocation to the plasma membraned of cells (Yu et al., 2013) , as well as long chain fatty acid transport protein 1 (SLC27A1), which plays a pivotal role mediating the ATP-dependent import of long-chain fatty acids into the cell by mediating their translocation at the plasma membrane (Ochiai et al., 2019) (Figure 7C ). In addition, the results also showed a clear pattern of genes that were only expressed in HSPC BM cells of IL32 rs4786370 CC individuals at D90 post vaccination ( Figure 7D ). These analyses revealed upregulation of genes associated with inflammatory immune response, DNA-binding transcription factor activity such as nuclear factor kB (NF-kB) subunit p65 (RELA) (Kunkl et al., 2019) , bromodomain-containing 7 (BRD7), and hepatocyte nuclear factor 1-beta (HNF1b) (Wu et al., 2017; Park et al., 2014) , a gene associated with the activation of inflammasome machinery such as NLR family pyrin domain containing 1 (NLRP1) (Finger et al., 2012) , as well as transmembrane signaling receptor activity such as tumor necrosis factor receptor superfamily member 8 (TNFRSF8) (Luo et al., 2018) ( Figure 7D) .
These data strengthen the finding that IL-32 is a crucial component in the regulation of events occurring at the level of the hematopoietic stem progenitor cells, which confer the development of the trained immunity phenotype leading to protection against L. braziliensis infections.
DISCUSSION
Several recent studies describe the ability of human innate immune cells to build a de facto immunological memory against pathogens and microbial products (Kleinnijenhuis et al., 2012; Netea et al., 2016) . The fungal cell wall component b-glucan is a prototypical inducer of trained immunity in vitro and in vivo, stimulating a long-term pro-inflammatory macrophage phenotype capable of mounting an augmented response to infection. Importantly, the trained immunity response is heightened nonspecifically, triggered by infections unrelated to the initial training stimulus (Ifrim et al., 2014) . In this series of experiments, we demonstrated that induction of trained immunity by b-glucan modulates IL-32-mediated control of Leishmania infection via IL-1 signaling and epigenetic changes. These findings improve our understanding of the mechanism of trained immunity induced by b-glucan and simultaneously point toward different avenues for pharmacotherapy for improved treatment of leishmaniasis.
Specifically, we have shown that induction of trained immunity by b-glucan increases the efficiency of phagocytosis and killing of L. braziliensis, in parallel with increased cytokine production, specifically IL-6 and IL-10. It has previously been demonstrated that dectin-1 and the complement receptor 3 (CR3) receptors are required to induce training of monocytes with b-glucan . These findings could at least partly explain the increased capacity for phagocytosis by b-glucan-trained cells, because both dectin-1 and CR3 are reportedly involved in Leishmania uptake by macrophages (Martínez-Ló pez et al., 2018) . Considering macrophage microbicidal activity, we assessed induction of ROS and NO production (Novais et al., 2009 ). However, b-glucan training did not alter any of these mediators. These results are in line with previous findings that reported no differences in ROS and NO induction in b-glucan-trained cells compared with naive cells. On the other hand, b-glucan-trained cells produced higher levels of antimicrobial peptides such as cathelicidin and b-defensin 2, which have been previously associated with improved killing of Leishmania spp. in human macrophages (Dos Santos et al., 2017b; Kulkarni et al., 2011) .
Because IL-32 has been described as a crucial mediator to control Leishmania infections through transcriptional induction of antimicrobial peptides, we explored the role of IL-32 in b-glucan-induced trained immunity. Significant induction of IL-32 expression suggested that b-glucan training influenced gene regulatory mechanisms. Indeed, histone methylation changes, namely H3K4me3 enrichment, are induced by b-glucan at the promoters of numerous pro-inflammatory genes such as TNF-a and IL-6 . In contrast, we observed that the IL-32 gene promotor region became depleted of H3K4me3 upon training with b-glucan. Importantly, we identified a training-specific H3K4me1 enhancer signature located downstream of the IL-32 gene transcription start site. Enhancers are distal cis-regulatory elements essential to controlling gene expression programs (Schaffner, 2015) and are thought to play crucial roles in the establishment of distinct macrophage phenotypes (Denisenko et al., 2017) . Recently, it has been demonstrated that this particular enhancer element modulates the expression of the different isoforms of IL-32 to regulate inflammatory states of immune cells during HIV-1 infection (Palstra et al., 2018) . Thus, from our limited profiling of the chromatin landscape surrounding IL-32 transcriptional regulation, it might be tempting to speculate that activating histone modifications at distal regulatory elements may be more important for IL-32 expression than those at proximal elements.
However, the importance of the IL-32 promoter cannot be overlooked, as shown by the fact that the expression of IL-32 is also altered by promoter SNPs (Westra et al., 2013) . The CC genotype of IL-32 rs4786370 SNP was previously associated with enhanced IL-32 protein production. We therefore examined the effect of this particular SNP in b-glucan-induced trained immunity. In accordance with previous reports (Plantinga et al., 2013) , we found that TNF-a, IL-6, and lactate production were higher in individuals carrying the CC genotype compared with those carrying the TT genotype in b-glucan-trained cells. Moreover, by assessing the influence of the IL32 promoter SNP on the infection index, we demonstrated that besides its important role for cytokine production in LPS restimulated macrophages, IL-32 levels were negatively associated with infection index rates in individuals carrying the CC genotype. What is the direct role of IL-32 in the induction of trained innate immunity is not known at this moment. However, because IL-32 is mainly expressed intracellularly in b-glucan-trained macrophages, it might be that IL-32 is acting like other intracellular cytokines such as IL-1a, IL-33, and IL-37 (Dinarello, 2011; Moorlag et al., 2018) . In addition, a recent study has pointed that IL-32 also can function as a transcription factor, because it appears to bind to DNA impairing the transcription and viral replication during infections (Kim et al., 2018) . Further work is required in order to understand the mechanistic significance of IL-32 in b-glucan-trained macrophages, including epigenetic mechanisms not explored in the current study such as DNA methylation (Meyer et al., 2015) , as well as transcription factor binding.
It has previously been shown that IL-32 is able to induce several proinflammatory cytokines, such as IL-1b, IL-8, and TNF-a. Furthermore, IL-1 and TNF-a can induce IL-32 (Heinhuis et al., 2011; Kim et al., 2005; Netea et al., 2005) . Recent reports pointed toward a role for IL-1 in the induction of b-glucaninduced trained immunity in vivo (Mitroulis et al., 2018) . In addition, Arts et al. (2018) demonstrated that IL-1b itself can induce trained immunity. In the present study, we were able demonstrate that IL-32 and IL-1 regulate the expression of each other in the context of trained innate immunity. Here, we showed that the IL32 rs4786370 is associated with IL-1b production during the early stages of training with b-glucan. Additionally, IL-1b protein was higher at the lesion of b-glucan-treated IL-32gTG mice after 3 weeks of infection. On the other hand, IL-1b itself also upregulates the production of IL-32. Moreover, we confirmed the role of IL-1 in the induction of trained immunity by using functional genomic analysis and IL-1 receptor blockade. Inhibition of IL-1 signaling downregulated IL-32 expression, which in turn decreased the killing of Leishmania parasites. Of note, we cannot exclude that the presence of IL-1b as a detrimental consequence, resulting in of chronic inflammation. IL-1b has been previously associated with CD8 + cell-mediated toxicity in lesions of patients with cutaneous leishmaniasis (Novais et al., 2017) . Furthermore, it cannot be discounted that the IL-1-dependent TNF-a and IL-6 induction after b-glucan training might also play a role in the induction of IL-32, therefore contributing to the killing of Leishmania parasites. As demonstrated previously (Heinhuis et al., 2011) , IL-32 and TNF-a are part of an inflammatory loop. Moreover, TNF-a has also been associated with IL-32 in ML caused by L. braziliensis (Galdino et al., 2014) .
As the results indicated that IL-32 is important for b-glucaninduced trained immunity in human macrophages in vitro, we evaluated the effect of b-glucan-induced trained immunity in human IL-32gTG mice infected with L. braziliensis. In these mice, b-glucan training induced proliferation of bone marrow cells. In addition, in agreement with the results previously shown by Mitroulis et al. (2018) using WT mice, we suggested that myeloid cells might be playing the major role in control the infection caused by L. braziliensis in IL32gTG mice. Furthermore, an enhanced IL-32 and IL-1b expression, as well as upregulation of genes involved in glycolysis, upon exposure to LPS or lysates of L. braziliensis was reported (Figure 4 ). Once again, these findings are in line with those from a previous study, in which changes in progenitor cells of WT mice such as increased production of IL-1b and enhanced glycolysis accompany the induction of trained innate immunity Mitroulis et al., 2018) . Moreover, it was also shown that BCG influences hematopoietic stem cells to generate epigenetically modified macrophages that provide significantly better protection against M. tuberculosis infection (Kaufmann et al., 2018) . Of great interest, as a proof of concept, we were able to demonstrate that after BCG vaccination of healthy individuals, IL-32 has effects at the level of BM progenitor cells by modulating signature genes associated with inflammation, DNA binding transcript factors, and metabolism, including pathways known to be important for the long-term induction of trained immunity (Mulder et al., 2019) . Netea et al. (2008) previously described that IL-32 contributes to differentiating monocytes into macrophage-like cells, resembling the phenotypical changes seen after b-glucan exposure. Additionally, IL-32 modulates the expression of ABCA1 and ABCG1 resulting in changes in lipid concentrations in primary human hepatocytes . Although we have not evaluated deviations in lipid metabolism, it is likely that IL-32 plays a role in metabolic changes necessary for cell adaptation during the induction phase of trained immunity with b-glucan.
Successful treatment of leishmaniasis is limited in the most parts of the world due to the toxicity and costs of effective medication. Moreover, a functional vaccine against the Leishmania spp. infections in human is still under development. However, a safe and effective leishmaniasis vaccine might be based on whole irradiated live parasites or Leishmania fractions, such as Leishmania-derived recombinant poly-protein (LEISH-F), as well as DNA vaccines (Rezvan and Moafi, 2015) . It would be of considerable interest to combine vaccine components that target the enhancement of Th1 responses against Leishmania with strategies such as induction of trained immunity, especially to improve memory development for long-term protection. In therapy, especially in the cases where an acquired immune response is not present or is not effective such as in DCL, induction of trained immunity may be crucial to contain the parasite proliferation and dissemination. As a proof of concept, treatment of patients with DCL with BCG provides control of parasites and long periods without relapses, improving the quality of the patient life (Convit et al., 2004; Pereira et al., 2009) . Thus, in addition to BCG training, b-glucan training represents another approach to control leishmaniasis in these patients. Moreover, b-glucan treatment may be an alternative when BCG, after several injections, could no longer be used due to the induction of strong acquired immune response in the local site of injection (Pereira et al., 2009 ).
In conclusion, we have shown that b-glucan improves host defense against L. braziliensis via the induction of trained immunity, highlighting IL-1 signaling and IL-32g as important mediators for the eradication of Leishmania parasites. This study represents a definitive characterization of the role of IL-32g in the trained phenotype induced by b-glucan. Our results begin to unravel the molecular mechanisms governing trained immunity and Leishmania infection control. Finally, the demonstration that b-glucan is able to improve the control of Leishmania infection using several mechanisms opens the gates for treatment strategies using trained immunity.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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This study was supported in part by the Coordenação de Aperfeiç oamento de Pessoal de Nível Superior ( 37 C and infected with stationary-phase promastigotes of L. braziliensis (2.5 3 10 6 /well; MOI 5:1). Percentage of infected macrophages, number of parasites per infected cells and infection index were measured after 2 h, 4 h and 24 h of infection. 1 3 10 5 cells in a final volume of 100 mL of culture medium were added into flat-bottom 96-well plates (Corning, NY, USA) , adhered for 1 h at 37 C and restimulated with 10 ng/mL of lipopolysaccharide (LPS) from E. coli serotype O55:B5, (Sigma-Aldrich), further purified as described (Battisti and Minnick, 2008) and stationary-phase L. braziliensis promastigotes (5 3 10 5 /well; MOI 5:1). Supernatants were collected after 2 h, 4 h and 24 h and stored at À20 C. In some experiments cells were pre-incubated (before b-glucan) for 1 h with 10 mg/mL of recombinant interleukin-1 receptor antagonist (IL-1Ra; Synergen, USA) to evaluate the IL-1 effects during the priming with b-glucan. After 24 h stimuli and inhibitors were washed away and the assay continued as described above. Additionally, 1 3 10 6 monocytes were stimulated with 10 ng/mL of rhIL-1b (R&D systems) for 24 h at 37 C. After 24 h cells were stored in 200 mL of TRIzol until RNA extraction.
Evaluation of Macrophage infection
Infection index were performed as previously described (Dos Santos et al., 2017b) . Coverslips were collected, cells were fixed and stained with Giemsa (Merck Millipore) and analyzed under a light microscope (1000x) to determine the infection index. Three hundred cells were analyzed and the percentage of infected cells and the mean number of intracellular parasites per infected cell (at least 50) were determined. Infection index = percentage of infected cells 3 mean number of parasites per infected cell.
